Rockefeller Capital Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Rockefeller Capital Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.25M	Sell	18,863 -303	-2%	-$17.8K	﹤0.01%	1586
2026 Q1	$1.04M	Sell	19,166 -877	-4%	-$48.9K	﹤0.01%	1597
2025 Q4	$1.12M	Buy	20,043 +627	+3%	+$32.5K	﹤0.01%	1508
2025 Q3	$931K	Sell	19,416 -979	-5%	-$43.8K	﹤0.01%	1453
2025 Q2	$828K	Sell	20,395 -36,945	-64%	-$1.49M	﹤0.01%	1396
2025 Q1	$2.51M	Buy	+57,340	New	+$2.53M	0.01%	945
2023 Q1	–	Sell	-3,014	Closed	-$123K	–	3916
2022 Q4	$123K	Buy	+3,014	New	+$125K	﹤0.01%	1923
2022 Q3	–	Sell	-5,199	Closed	-$218K	–	4437
2022 Q2	$218K	Buy	+5,199	New	+$218K	﹤0.01%	1602

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Evelyn Partners London $46.9B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Rockefeller Capital Management's XPH Position: Q2 2026 in Review

Rockefeller Capital Management reduced its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 1.6% in Q2 2026, selling an estimated $17.8K and leaving 18,863 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1586.

Rockefeller Capital Management first reported a position in XPH in Q2 2022 and has held it in 8 quarters since. The position peaked at $2.51M in Q1 2025. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

Rockefeller Capital Management held 18,863 shares of State Street SPDR S&P Pharmaceuticals ETF worth $1.25M as of Q2 2026.
Rockefeller Capital Management sold 303 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $17.8K.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1586 holding.
Rockefeller Capital Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2022 and has held it in 8 quarters since.
Rockefeller Capital Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $2.51M in Q1 2025.
93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.